Positive topline results announced from Phase 2a clinical trial of RAP-219 in patients with focal onset seizures Phase 2 ...
Completed enrollment in Phase 2 LOTUS trial of AVTX-009 for the treatment of hidradenitis suppurativa; topline data expected mid-2026Appointed Kevin Lind to Board of DirectorsExpanded leadership team ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback